
Milestone Scientific Inc.
MLSSAMEXHealthcareMedical - Instruments & Supplies
Previous close
$0.4808
+$0.0105 · +2.23%
MLSS company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Hold
Wait — insufficient conviction to act
Valuation
57
Fair Value
Momentum
48
Neutral
Sentiment
43
Mixed
Risk resilience
31
High Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteMilestone Scientific Inc. is dedicated to the innovation, refinement, and global distribution of advanced diagnostic and therapeutic injection technologies and devices. These solutions cater to the medical, dental, and cosmetic industries, with a presence in the United States, China, and other international markets. The company's operations are divided into two main segments: Dental and Medical. Within its Dental division, key products include CompuDent and the STA Single Tooth Anesthesia System, both instrumental for delivering local anesthetics across all dental procedures. For broader applications, the firm offers CompuFlo, a sophisticated computer-controlled system capable of delivering drugs, anesthetics, and other medicaments comfortably and precisely, as well as aspirating bodily fluids or prior injections. Complementing this, a disposable injection handpiece provides precise tactile control during administration. In the Medical segment, Milestone Scientific introduces the CompuFlo Epidural, a computer-guided anesthesia system designed for a variety of medical applications. Additionally, their CompuMed system is utilized in numerous specialized procedures, including plastic surgery, hair restoration, colorectal surgery, podiatry, dermatology, and orthopedics, among others. Headquartered in Livingston, New Jersey, Milestone Scientific Inc. was established in 1989.
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Eric C. Hines
- Listed since
- Nov 3, 1995
- Employees
- 15
Market position
Day range
Current $0.4808
52-week range
Current $0.4808
- Open
- $0.48
- Previous close
- $0.4703
- Volume
- 85.69K
- 0.33× average
- Average volume
- 263.61K
- Average daily volume
- Market cap
- 42.53M USD
- Beta
- 1.05
- Market reference 1
- 50-day average
- $0.4036
- +19.13% above average
- 200-day average
- $0.338
- +42.25% above average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 22.31M USD
- EV / EBITDA
- -4.05×
- Earnings yield
- -25.54%
- Free cash flow yield
- -13.09%
Profitability & efficiency
- Return on equity
- -203.45%
- Return on assets
- -73.30%
- Return on invested capital
- -148.63%
Financial health
- Current ratio
- 1.81×
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 8.97M USD | 8.63M USD | 9.83M USD | 8.81M USD | 10.3M USD |
| Cost of goods sold | 2.64M USD | 2.2M USD | 3.03M USD | 3.91M USD | 3.99M USD |
| Gross profit | 6.33M USD | 6.43M USD | 6.79M USD | 4.9M USD | 6.31M USD |
| Research and development | 449.47K USD | 858.77K USD | 701.38K USD | 1.15M USD | 878.21K USD |
| Selling, general, and administrative | 11.58M USD | — | — | — | — |
| Operating expenses | 12.03M USD | 13.19M USD | 13.9M USD | 13.73M USD | 13.69M USD |
| Interest income | — | 60.27K USD | 125.53K USD | 54.61K USD | — |
| Interest expense | 25.6K USD | — | — | — | 16.36K USD |
| Depreciation and amortization | 185.66K USD | 37.45K USD | 62.32K USD | 63.84K USD | 73.84K USD |
| Operating income | −5.7M USD | −6.76M USD | −7.11M USD | −8.83M USD | −7.38M USD |
| Net income | −5.72M USD | −4.71M USD | −6.93M USD | −8.71M USD | −6.82M USD |
Company facts updated Aug 24, 2026.
ETFs holding MLSS
Funds reporting this stock among their holdings, ordered by reported position size.
Continue in GoAI
Research MLSSresearch.disclaimer

